−108JPY
−1.94 BJPY
63.04 MJPY
18.08 M
About ONCOLYS BIOPHARMA INC
Sector
Industry
Headquarters
Tokyo
Website
Employees (FY)
34
Founded
2004
ISIN
JP3202170001
FIGI
BBG005HVWTC9
Oncolys BioPharma, Inc. engages in the research and development of cancer treatment therapy and diagnostics which include early detection, loco-regional therapy, prognostic test, and systemic treatments. It operates through the Pharmaceutical and Diagnostics segments. The Pharmaceutical segment deals with the research, development, manufacture, and sale of pharmaceutical products. The Diagnostics segment engages in the research, development, manufacture, and sale of test agents and equipment as well as the provision of testing services. The company was founded by Yasuo Urata on March 18, 2004 and is headquartered in Tokyo, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 4588 is 668 JPY — it has decreased by 4.30% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange ONCOLYS BIOPHARMA INC stocks are traded under the ticker 4588.
ONCOLYS BIOPHARMA INC is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
4588 stock is 11.68% volatile and has beta coefficient of 0.79. Check out the list of the most volatile stocks — is ONCOLYS BIOPHARMA INC there?
Yes, you can track ONCOLYS BIOPHARMA INC financials in yearly and quarterly reports right on TradingView.
4588 stock has fallen by 2.62% compared to the previous week, the month change is a 7.74% rise, over the last year ONCOLYS BIOPHARMA INC has showed a 2.14% increase.
4588 net income for the last quarter is −665.66 M JPY, while the quarter before that showed −404.08 M JPY of net income which accounts for −64.73% change. Track more ONCOLYS BIOPHARMA INC financial stats to get the full picture.
Today ONCOLYS BIOPHARMA INC has the market capitalization of 14.16 B, it has decreased by 3.76% over the last week.
No, 4588 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 4588 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ONCOLYS BIOPHARMA INC stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 34.00 employees. See our rating of the largest employees — is ONCOLYS BIOPHARMA INC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ONCOLYS BIOPHARMA INC technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ONCOLYS BIOPHARMA INC stock shows the neutral signal. See more of ONCOLYS BIOPHARMA INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ONCOLYS BIOPHARMA INC EBITDA is −1.93 B JPY, and current EBITDA margin is −3.06 K%. See more stats in ONCOLYS BIOPHARMA INC financial statements.